Aspire Private Capital’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
SSM
DRZID
Aspire Private Capital's OGN Position: Q4 2024 in Review
Aspire Private Capital sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 91 shares — an estimated $1.74K sold.
Aspire Private Capital first reported a position in OGN in Q2 2021 and held it in 14 quarters. The position peaked at $8K in Q2 2022. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.
- Aspire Private Capital reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
- Aspire Private Capital sold 91 Organon & Co shares in Q4 2024, an estimated $1.74K.
- Aspire Private Capital first reported a position in Organon & Co in Q2 2021 and held it in 14 quarters.
- Aspire Private Capital's Organon & Co position peaked at $8K in Q2 2022.
- 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.
Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.